The mechanism(s) of action of the benzodiazepines.
D000241:Adenosine / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D001569:Benzodiazepines / Q000494:pharmacology* / Q000627:therapeutic use; D002110:Caffeine / Q000009:adverse effects / Q000378:metabolism; D002243:Carbolines / Q000378:metabolism / Q000627:therapeutic use; D002415:Cats; D002417:Cattle; D003975:Diazepam / Q000378:metabolism; D006801:Humans; D008970:Molecular Weight; D009126:Muscle Relaxation / Q000187:drug effects; D018377:Neurotransmitter Agents / Q000378:metabolism; D009536:Niacinamide / Q000378:metabolism / Q000494:pharmacology; D011687:Purines / Q000378:metabolism; D051381:Rats; D011956:Receptors, Cell Surface / Q000187:drug effects; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D012640:Seizures / Q000188:drug therapy; D012893:Sleep Wake Disorders / Q000188:drug therapy; D005680:gamma-Aminobutyric Acid / Q000378:metabolism / Q000494:pharmacology
D014151:Anti-Anxiety Agents; D002243:Carbolines; D018377:Neurotransmitter Agents; D011687:Purines; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D017981:Receptors, Neurotransmitter; D001569:Benzodiazepines; D009536:Niacinamide; D002110:Caffeine; D005680:gamma-Aminobutyric Acid; C024915:beta-carboline-3-carboxylic acid ethyl ester; C025960:N(6)-(2-(4-chlorophenyl)bicyclo(2.2.2.)-octyl)(3)-adenosine; D000241:Adenosine; D003975:Diazepam